“…Although reports of σ 2 ligands abound in the literature (Bertha et al, 1995;Bowen et al, 1995a,b;Kassiou et al, 2005;Mach et al, 1995;Maeda et al, 2002;Maier and Wunsch, 2002;Perregaard et al, 1995;Vangveravong et al, 2006), the primary criterion for these claims appears to be reasonable affinity for this receptor subtype relative to σ 1 , with little consideration for selectivity as compared to non-σ binding sites. In addition, the few σ 2 compounds that have been tested in functional studies appear to act as agonists (Bowen et al, 1995a,b;Crawford et al, 2002;Vilner and Bowen, 2000).…”